Han Yusheng 4

What Happened
Han Yusheng, a director of Burning Rock Biotech Ltd (BNR), made a series of purchases of American Depositary Shares (ADS) between June 11 and June 26, 2026. He acquired a total of 731,410 ADS for aggregate consideration of approximately $6,182,172. Reported purchase prices per ADS ranged from $7.45 to $9.25. These are purchases (reported with code "P"), which are generally viewed as more informative than routine sales.

Key Details

• Transaction dates and amounts (ADS @ price — value):
  • 2026-06-11: 24,760 ADS @ $8.74 = $216,388
  • 2026-06-12: 210,000 ADS @ $9.25 = $1,942,143
  • 2026-06-16: 111,110 ADS @ $9.00 = $999,957
  • 2026-06-22: 104,650 ADS @ $7.45 = $779,674
  • 2026-06-23: 5,990 ADS @ $7.50 = $44,920
  • 2026-06-24: 250,000 ADS @ $8.00 = $2,000,000
  • 2026-06-26: 24,900 ADS @ $8.00 = $199,090
• Total: 731,410 ADS purchased for ≈ $6,182,172.
• ADS to ordinary share ratio: 1 ADS = 10 Class A ordinary shares (footnote F1) → purchases equal ~7,314,100 underlying ordinary shares.
• Reported price is per ADS (footnote F2).
• Method: reported as open market or private purchases (code "P"); filing does not specify which for each lot.
• Shares owned after transaction: not provided in the supplied summary.
• Filing date: Form 4 filed July 2, 2026, covering transactions June 11–26, 2026.

Context
These were outright purchases (not option exercises, gifts, or grants). Purchases by insiders are often watched by retail investors as a stronger signal of confidence than sales, but filings alone do not reveal the insider’s motivation. If you need confirmation of post-transaction beneficial ownership or whether any trades were done under a trading plan (e.g., 10b5-1), consult the full Form 4 filing (Accession 0001193125-26-293511) for complete disclosures.